STEVENS-JOHNSON SYNDROME FOLLOWING LONG-ACTING SULPHONAMIDES.
D000917:Antibody Formation; D000941:Antigens; D001327:Autoimmune Diseases; D003875:Drug Eruptions; D006634:Histamine H1 Antagonists; D007097:Imines; D012157:Mononuclear Phagocyte System; D010640:Phenothiazines; D011398:Promethazine; D011809:Quinones; D013262:Stevens-Johnson Syndrome; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D014116:Toxicology
D000941:Antigens; D006634:Histamine H1 Antagonists; D007097:Imines; D010640:Phenothiazines; D011809:Quinones; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D011398:Promethazine; C031637:phenothiazine
ANTIBODY FORMATION; ANTIGENS; ANTIHISTAMINICS; AUTOIMMUNE DISEASES; DERMATITIS MEDICAMENTOSA; IMINES; PHENOTHIAZINES; PROMETHAZINE; QUINONES; RETICULOENDOTHELIAL SYSTEM; STEVENS-JOHNSON SYNDROME; SULFONAMIDES; TOXICOLOGIC REPORT